The occurrence of endocrine differentiation in some mammary carcinomas
seems well-established, but pathologists continue to debate its signi
ficance. Contemporary thinking suggests that endocrine tumours of the
breast do not constitute a single clinicopathological entity with a co
nsistent histogenesis but rather that ens docrine differentiation repr
esents a pathway of neoplastic development available to a range of bre
ast cancers. This pattern of differentiation occurs in tumours with va
stly different morphological appearances, such as: ductal carcinoma in
situ, mucinous carcinoma, a variant of lobular carcinoma, and low gra
de invasive ductal carcinoma. Although such tumours share some charact
eristics with intestinal endocrine neoplasms, the typical pattern of i
ntestinal carcinoid virtually never occurs in mammary lesions. Convent
ional microscopy permits the diagnosis in most cases. Specialized tech
niques (histochemistry, immunohistochemistry, and electron microscopy)
can serve as the basis for diagnosis in the absence of the appropriat
e morphological features. Although the system of nomenclature proposed
by the World Health Organization for use with endocrine tumours in ot
her organs can be used for endocrine tumours of the breast, only a min
ority of lesions will fit the established criteria. Most lesions are c
lassifiable in the conventional categories of mammary carcinomas. No s
pecial prognostic significance is attached to these tumours at the pre
sent time.